معرفی
Dr. Natalie Trevaskis is an Associate Professor at Monash University's Faculty of Pharmacy and Pharmaceutical Sciences and Head of the Lymphatic Medicine Laboratory at the Monash Institute of Pharmaceutical Sciences. Her work focuses on lymphatic dysfunction in diseases like arthritis, pancreatitis, and metabolic disorders, and developing lymph-targeted drug delivery systems. She holds an H-index of 27 and over 65 publications in top journals, including Nature and Nature Metabolism. Dr. Trevaskis has secured patents for lipid prodrugs licensed to Puretech Health and Boehringer Ingelheim.
- Education: BPharm (Gold Medal, 2001), PhD (Mollie Holman Medal, 2006), Monash University.
- Research Interests: Lymphatic biology, drug delivery systems (liposomes, lipoproteins), metabolic diseases, and immunology.
Her lab includes 2 postdocs, 7 PhD students, and 2 honours students. She has supervised 13 completions, with students winning international awards. Dr. Trevaskis is a sought-after speaker, presenting at conferences like the International Lymphatic Forum and Gordon Research Conferences.
- Teaching Roles: Unit coordinator for PHR1022/PHR2021 in Master of Pharmacy programs, lecturing on drug delivery and pharmacokinetics.
Her professional roles include serving on the MIPS Animal Ethics Committee, editorial boards for Pharmaceutical Research and Journal of Pharmaceutical Science, and leading initiatives like the Melbourne Lymphatic Symposium since 2016.
